User profiles for Elisa Pin
Elisa PinSciLifeLab (Science for Life Laboratory), Dept Protein Science, KTH Royal Institute of … Verified email at scilifelab.se Cited by 1968 |
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
…, C Hellström, S Bayati, S Bergström, E Pin… - Nature …, 2020 - nature.com
SARS-CoV-2 may pose an occupational health risk to healthcare workers. Here, we report
the seroprevalence of SARS-CoV-2 antibodies, self-reported symptoms and occupational …
the seroprevalence of SARS-CoV-2 antibodies, self-reported symptoms and occupational …
The role of proteomics in prostate cancer research: biomarker discovery and validation
PURPOSE: Prostate Cancer (PCa) represents the second most frequent type of tumor in
men worldwide. Incidence increases with patient age and represents the most important risk …
men worldwide. Incidence increases with patient age and represents the most important risk …
The human secretome
The proteins secreted by human cells (collectively referred to as the secretome) are important
not only for the basic understanding of human biology but also for the identification of …
not only for the basic understanding of human biology but also for the identification of …
Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort
The drivers of critical coronavirus disease 2019 (COVID-19) remain unknown. Given major
confounding factors such as age and comorbidities, true mediators of this condition have …
confounding factors such as age and comorbidities, true mediators of this condition have …
Immunocapture strategies in translational proteomics
Aiming at clinical studies of human diseases, antibody-assisted assays have been applied
to biomarker discovery and toward a streamlined translation from patient profiling to assays …
to biomarker discovery and toward a streamlined translation from patient profiling to assays …
[HTML][HTML] Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
Background Recent reports demonstrate robust serological responses to a single dose of
messenger RNA (mRNA) vaccines in individuals previously infected with SARS-CoV-2. Data …
messenger RNA (mRNA) vaccines in individuals previously infected with SARS-CoV-2. Data …
Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B-and T-cell immunity during 13 months in consecutive patients
We studied clinical and immunological outcome of Covid-19 in consecutive CLL patients from
a well-defined area during month 1–13 of the pandemic. Sixty patients (median age 71 y, …
a well-defined area during month 1–13 of the pandemic. Sixty patients (median age 71 y, …
Persisting salivary IgG against SARS-CoV-2 at 9 months after mild COVID-19: a complementary approach to population surveys
… in-house enzyme-linked immunosorbent assay (ELISA) for samples taken prior to June 2020
(… Elecsys and the in-house ELISA determine antibodies against recombinant nucleocapsid …
(… Elecsys and the in-house ELISA determine antibodies against recombinant nucleocapsid …
Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood–brain barrier disruption and outcome prediction following severe traumatic …
Background Severe traumatic brain injury (TBI) is associated with blood–brain barrier (BBB)
disruption and a subsequent neuroinflammatory process. We aimed to perform a multiplex …
disruption and a subsequent neuroinflammatory process. We aimed to perform a multiplex …
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19
…, J Olofsson, L Skoglund, J Yousef, E Pin… - Journal of internal …, 2022 - Wiley Online Library
Background Emerging data support detectable immune responses for months after severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and vaccination, but it is …
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and vaccination, but it is …